Clinical Trial Update: Bovine Lactoferrin in Reducing Taste Disturbances in Patients With Colorectal Cancer Receiving Oxaliplatin-Based Chemotherapy [NA]

View source ↗

Summary

A completed clinical trial evaluating bovine lactoferrin to reduce taste disturbances in colorectal cancer patients receiving oxaliplatin-based chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bovine lactoferrin (lactoferrin, bovine)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Colorectal Cancer, Dysgeusia | NA | Status: COMPLETED